RESPeRATE is a medical device indicated for the adjunctive treatment of hypertension. The device utilizes a patented Interactive Respiratory-Pacing technology to reduce sympathetic neural activity and relax the muscles surrounding the small blood vessels, leading to a sustained reduction in blood pressure.
Pooled data from 7 separate clinical studies show an average high blood pressure reduction of 14/8 mmHg within 8 weeks of using the device. There were no side effects and no interactions with existing medications. The reductions were significant over control (P<0.005/0.002) and were in addition to those achieved through other hypertension therapies, including medications.
Please note: Although RESPeRATE does not require a prescription, it should only be used as part of the patient's overall health program for achieving goal blood pressure, as recommended by a physician.
For complete clinical information including journal re-prints, and information about the Take Control Sample Program, see www.resperate.com/md or call 877-988-9388.
InterCure, Inc.
Parker Plaza
400 Kelby St.
Fort Lee, NJ 07024
Phone: 201-720-7750
www.intercure.com
Direct Inquiries to:
(877) 988-9388 or HCP@resperate.com